See All Slides - tctmd.com

Slides

Presentation TCT 2012

Case 2: During an EVAR or TEVAR

Presenter: James McKinsey

October 23, 2012

Presentation TCT 2012

Early Human Clinical Studies: Patient Selection, Technical Considerations, and Endpoints(5)

Presenter: Paul Sobotka

October 23, 2012

Presentation TCT 2012

Introduction(10)

Presenter: Dennis McNamara

October 23, 2012

Presentation TCT 2012

Leveraging IT Systems to Improve Operational Performance

Presenter: Andrew Proctor

October 23, 2012

Presentation TCT 2012

TCT-55. Major Adverse Cardiac Events Associated with Discontinuation of Clopidogrel Treatment Within the First Year After Coronary Stent Implantation in Western Denmark

Presenter: Michael Maeng

October 23, 2012

Presentation TCT 2012

A Multidisciplinary Approach to CLI Is Essential: Wound Care, Risk Factor Modification, and Endovascular Therapy

Presenter: James Zidar

October 23, 2012

Presentation TCT 2012

Multivessel Disease and Left Main Intervention: Indications and Outcomes

Presenter: David Holmes Jr

October 23, 2012

Presentation TCT 2012

Surgery Is the Obvious Choice!

Presenter: Steven Bolling

October 23, 2012

Presentation TCT 2012

Perspective 2

Presenter: Christopher Nelson

October 23, 2012

Presentation TCT 2012

Do Beta Blockade, Afterload Reduction, and Other Medical Therapies Improve Prognosis in Functional MR? Review of the Literature and Practical Recommendations

Presenter: Jason Rogers

October 23, 2012

Advertisement

Slides

Case 2: During an EVAR or TEVAR

Early Human Clinical Studies: Patient Selection, Technical Considerations, and Endpoints(5)

Introduction(10)

Leveraging IT Systems to Improve Operational Performance

TCT-55. Major Adverse Cardiac Events Associated with Discontinuation of Clopidogrel Treatment Within the First Year After Coronary Stent Implantation in Western Denmark

A Multidisciplinary Approach to CLI Is Essential: Wound Care, Risk Factor Modification, and Endovascular Therapy

Multivessel Disease and Left Main Intervention: Indications and Outcomes

Surgery Is the Obvious Choice!

Perspective 2

Do Beta Blockade, Afterload Reduction, and Other Medical Therapies Improve Prognosis in Functional MR? Review of the Literature and Practical Recommendations

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content